Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-25T19:38:55.457Z Has data issue: false hasContentIssue false
  • English
  • Français

Hyperbaric oxygen therapy as salvage treatment for sudden sensorineural hearing loss: review of rationale and preliminary report

Published online by Cambridge University Press:  30 November 2009

E Muzzi ,
B Zennaro ,
R Visentin ,
F Soldano  and
C Sacilotto
E Muzzi*
Affiliation:
ENT Clinic, Santa Maria della Misericordia University Hospital, Udine, Italy
B Zennaro
Affiliation:
OTI Services Hyperbaric Medicine Service, Venice, Italy
R Visentin
Affiliation:
OTI Services Hyperbaric Medicine Service, Venice, Italy
F Soldano
Affiliation:
Department of Medical and Morphological Research, Statistics, University of Udine, Italy
C Sacilotto
Affiliation:
ENT Clinic, Santa Maria della Misericordia University Hospital, Udine, Italy
*
Address for correspondence: Dr Enrico Muzzi, ENT, Santa Maria della Misericordia University Hospital, 15 P.le Santa Maria della Misericordia I-33100 Udine, Italy. Fax: +390432471195 E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

The management of sudden sensorineural hearing loss has not yet been standardised. Hyperbaric oxygen therapy influences recovery from sudden sensorineural hearing loss, but the underlying mechanism is unknown and the appropriate indications and protocols undetermined.

Materials and methods:

Nineteen patients affected by sudden sensorineural hearing loss were treated after unsuccessful medical therapy, either in an acute or chronic setting. Pure oxygen inhalation at 2.5 atmospheres absolute pressure was administered for 90 minutes, for 30 sessions. Frequency-specific and average pure tone hearing thresholds were determined before and after hyperbaric oxygen therapy. The number of hyperbaric oxygen therapy sessions, the patient's age and any therapeutic delay were considered as quantitative variables possibly influencing outcome. Stepwise multivariate analysis was performed.

Results:

Salvage hyperbaric oxygen therapy appeared to improve patients' pure tone hearing thresholds, particularly at low frequencies. Positive results were more likely with increased patient age and reduced delay in receiving hyperbaric oxygen therapy.

Conclusion:

Hyperbaric oxygen therapy has a strong scientific rationale, and improves pure tone hearing thresholds in cases of sudden sensorineural hearing loss unresponsive to medical therapy. Further research may be able to identify those patients with sudden sensorineural hearing loss for whom hyperbaric oxygen therapy would be most cost-effective.

Keywords

Hyperbaric Oxygen TherapySudden Hearing Loss
Type
Online Only Main Article
Information
The Journal of Laryngology & Otology , Volume 124 , Issue 2 , February 2010 , e2
Copyright
Copyright © JLO (1984) Limited 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Conlin, AE, Parnes, LS. Treatment of sudden sensorineural hearing loss: I. A systematic review. Arch Otolaryngol Head Neck Surg 2007;133:573–81CrossRefGoogle ScholarPubMed
2O'Malley, MR, Haynes, DS. Sudden hearing loss. Otolaryngol Clin North Am 2008;41:633–49Google Scholar
3Rauch, SD. Clinical practice. Idiopathic sudden sensorineural hearing loss. N Engl J Med 2008;359:833–40Google Scholar
4Merchant, SN, Adams, JC, Nadol, JB Jr.Pathology and pathophysiology of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2005;26:151–60Google Scholar
5Ågrup, C, Luxon, LM. Immune-mediated inner-ear disorders in neuro-otology. Curr Opin Neurol 2006;19:26–32Google Scholar
6Xenellis, J, Nikolopoulos, TP, Stavroulaki, P, Marangoudakis, P, Androulakis, M, Tsangaroulakis, M et al. Simultaneous and sequential bilateral sudden sensorineural hearing loss: are they different from unilateral sudden sensorineural hearing loss? ORL J Otorhinolaryngol Relat Spec 2007;69:306–10Google Scholar
7Horn, CE, Himel, HN, Selesnick, SH. Hyperbaric oxygen therapy for sudden sensorineural hearing loss: a prospective trial of patients failing steroid and antiviral treatment. Otol Neurotol 2005;26:882–9Google Scholar
8Aslan, I, Oysu, C, Veyseller, B, Baserer, N. Does the addition of hyperbaric oxygen therapy to the conventional treatment modalities influence the outcome of sudden deafness? Otolaryngol Head Neck Surg 2002;126:121–6CrossRefGoogle Scholar
9Mazurek, B, Haupt, H, Georgiewa, P, Klapp, BF, Reisshauer, A. A model of peripherally developing hearing loss and tinnitus based on the role of hypoxia and ischemia. Med Hypotheses 2006;67:892–9Google Scholar
10Bennett, MH, Kertesz, T, Yeung, P. Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database Syst Rev 2007;(1):CD004739CrossRefGoogle ScholarPubMed
11Frantz, MC, Pontz, BF, Arnold, W. Hyperbaric oxygen treatment restores sudden hearing loss in a patient with Fabry disease. ORL J Otorhinolaryngol Relat Spec 2008;70:210–13Google Scholar
12Domachevsky, L, Keynan, Y, Shupak, A, Adir, Y. Hyperbaric oxygen in the treatment of sudden deafness. Eur Arch Otorhinolaryngol 2007;264:951–3CrossRefGoogle ScholarPubMed
13Italian Society of Anesthesia, Analgesia, Resuscitation, Intensive Care (SIAARTI), Italian Society of Undersea and Hyperbaric Medicine (SIMSI) and Private Hyperbaric Chambers National Association (ANCIP) Study Group. Guidelines on the indications of hyperbaric oxygen therapy. 13. Sudden deafness [in Italian]. Med Sub Iperb 2007;26:29Google Scholar
14Plontke, SK, Bauer, M, Meisner, C. Comparison of pure-tone audiometry analysis in sudden hearing loss studies: lack of agreement for different outcome measures. Otol Neurotol 2007;28:753–63Google Scholar
15Wei, BP, Mubiru, S, O'Leary, S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 2006;(1):CD003998CrossRefGoogle ScholarPubMed
16Conlin, AE, Parnes, LS. Treatment of sudden sensorineural hearing loss: II. A meta-analysis. Arch Otolaryngol Head Neck Surg 2007;133:582–6Google Scholar
17Suckfüll, M. Hearing Loss Study Group. Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet 2002;360:1811–17Google Scholar
18Klemm, E, Bepperling, F, Burschka, MA, Mösges, R; Study Group. Hemodilution therapy with hydroxyethyl starch solution (130/0.4) in unilateral idiopathic sudden sensorineural hearing loss: a dose-finding, double-blind, placebo-controlled, international multicenter trial with 210 patients. Otol Neurotol 2007;28:157–70Google Scholar
19Westerlaken, BO, de Kleine, E, van der Laan, B, Albers, F. The treatment of idiopathic sudden sensorineural hearing loss using pulse therapy: a prospective, randomized, double-blind clinical trial. Laryngoscope 2007;117:684–90CrossRefGoogle ScholarPubMed
20Banerjee, A, Parnes, LS. Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss. Otol Neurotol 2005;26:878–81Google Scholar
21Agarwal, L, Pothier, DD. Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss. Protocol. Cochrane Database Syst Rev 2009;(4):CD003422Google Scholar
22Awad, Z, Natt, RS, Pothier, DD. Antivirals for idiopathic sudden sensorineural hearing loss. Protocol. Cochrane Database Syst Rev 2008;(1):CD006987Google Scholar
23Cadoni, G, Scipione, S, Agostino, S, Addolorato, G, Cianfrone, F, Leggio, L et al. Coenzyme Q 10 and cardiovascular risk factors in idiopathic sudden sensorineural hearing loss patients. Otol Neurotol 2007;28:878–83Google Scholar
24Fujimura, T, Suzuki, H, Shiomori, T, Udaka, T, Mori, T. Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2007;264:861–6Google Scholar
25Racic, G, Maslovara, S, Roje, Z, Dogas, Z, Tafra, R. Hyperbaric oxygen in the treatment of sudden hearing loss. ORL J Otorhinolaryngol Relat Spec 2003;65:317–20Google Scholar
26Kawamata, T, Ohki, S, Sakuma, T, Suzaki, H. Combination steroid and hyperbaric oxygenation therapy for sudden idiopathic sensorineural hearing loss [in Japanese]. Nippon Jibiinkoka Gakkai Kaiho 2007;110:395–402Google Scholar
27Suzuki, H, Fujimura, T, Shiomori, T, Ohbuchi, T, Kitamura, T, Hashida, K et al. Prostaglandin E1 versus steroid in combination with hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx 2008;35:192–7Google Scholar
28Çekin, E, Cincik, H, Ulubil, SA, Gungor, A. Effectiveness of hyperbaric oxygen therapy in management of sudden hearing loss. J Laryngol Otol 2009, 123, 609–12Google Scholar
29Undersea and Hyperbaric Medical Society (UHMS) Hyperbaric Oxygen Therapy Committee. Hyperbaric oxygen 2003: indications and results. In: Feldmeier, JJ, ed. The Hyperbaric Oxygen Therapy Committee Report. Kensington, Maryland, USA: Undersea and Hyperbaric Medical Society, 2003Google Scholar
30Medicare Services Advisory Committee (MSAC). Hyperbaric Oxygen Therapy. Canberra, Australia: Commonwealth Department of Health and Ageing, 2000;1018–20Google Scholar
31Narożny, W, Kuczkowski, J, Mikaszewski, B. HBO effectively supports SSNHL therapy. Eur Arch Otorhinolaryngol 2005;262:163–4Google Scholar
32Murakawa, T, Kosaka, M, Mori, Y, Fukazawa, M, Misaki, K. Treatment of 522 patients with sudden deafness using oxygenation at high pressure [in Japanese]. Nippon Jibiinkoka Gakkai Kaiho 2000;103:506–15Google Scholar
33Topuz, E, Yigit, O, Cinar, U, Seven, H. Should hyperbaric oxygen be added to treatment in idiopathic sudden sensorineural hearing loss? Eur Arch Otorhinolaryngol 2004;261:393–6Google Scholar
34Orita, S, Fukushima, K, Orita, Y, Nishizaki, K. Sudden hearing impairment combined with diabetes mellitus or hyperlipidemia. Eur Arch Otorhinolaryngol 2007;264:359–62Google Scholar
35Ben Gamra, O, Mbarek, C, Ben Rejab, I, Hariga, I, Bhar, H, Sghaier, L et al. Idiopathic sudden sensorineural hearing loss. What's the appropriate management? [in French] Tunis Med 2007;85:839–42Google Scholar
36Fattori, B, Berrettini, S, Casani, A, Nacci, A, De Vito, A, De Iaco, G. Sudden hypoacusis treated with hyperbaric oxygen therapy: a controlled study. Ear Nose Throat J 2001;80:655–60Google Scholar
37Kau, RJ, Sendtner-Gress, K, Ganzer, U, Arnold, W. Effectiveness of hyperbaric oxygen therapy in patients with acute and chronic cochlear disorders. ORL J Otorhinolaryngol Relat Spec 1997;59:79–83Google Scholar
38Nagahara, K, Fisch, U, Yagi, N. Perilymph oxygenation in sudden and progressive sensorineural hearing loss. Acta Otolaryngol 1983;96:57–68Google Scholar
39Rossignol, DA. Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism. Med Hypotheses 2007;68:1208–27Google Scholar
40Hills, BA. A role for oxygen-induced osmosis in hyperbaric oxygen therapy. Med Hypotheses 1999;52:259–63Google Scholar
41Riva, C, Donadieu, E, Magnan, J, Lavieille, JP. Age-related hearing loss in CD/1 mice is associated to ROS formation and HIF target proteins up-regulation in the cochlea. Exp Gerontol 2007;42:327–36CrossRefGoogle ScholarPubMed
42Granowitz, EV, Skulsky, EJ, Benson, RM, Wright, J, Garb, JL, Cohen, ER et al. Exposure to increased pressure or hyperbaric oxygen suppresses interferon-gamma secretion in whole blood cultures of healthy humans. Undersea Hyperb Med 2002;29:216–25Google Scholar
43Tompach, PC, Lew, D, Stoll, JL. Cell response to hyperbaric oxygen treatment. Int J Oral Maxillofac Surg 1997;26:82–6Google Scholar
44Jadczak, M, Rapiejko, P, Kantor, I, Szczygielski, K, Usowski, J, Piechocki, J et al. Evaluation of hyperbaric oxygen and pharmacological therapy in sudden hearing loss [in Polish]. Otolaryngol Pol 2007;61:887–91CrossRefGoogle ScholarPubMed
45Čvorović, L, Đeric, D, Probst, R, Hegemann, S. Prognostic model for predicting hearing recovery in idiopathic sudden sensorineural hearing loss. Otol Neurotol 2008;29:464–9Google Scholar
46Satar, B, Hidir, Y, Yetiser, S. Effectiveness of hyperbaric oxygen therapy in idiopathic sudden hearing loss. J Laryngol Otol 2006;120:665–9Google Scholar
47Nakashima, T, Naganawa, S, Sone, M, Tominaga, M, Hayashi, H, Yamamoto, H et al. Disorders of cochlear blood flow. Brain Res Brain Res Rev 2003;43:17–28Google Scholar
48Castro, NP Jr, Almeida, CI, Campos, CA. Sudden sensorineural hearing loss and vertigo associated with arterial occlusive disease: three case reports and literature review. Sao Paulo Med J 2007;125:191–5Google Scholar
49Ylikoski, J, Mrena, R, Makitie, A, Kuokkanen, J, Pirvola, U, Savolainen, S. Hyperbaric oxygen therapy seems to enhance recovery from acute acoustic trauma. Acta Otolaryngol 2008;128:1–7Google Scholar
50Hoffmann, G, Bohmer, D, Desloovere, C. Hyperbaric oxygenation as a treatment of chronic forms of inner ear hearing loss and tinnitus. In: Li, W, Cramer, FS, eds. Proceedings of the Eleventh International Congress on Hyperbaric Medicine, Fuzhou, China. Flagstaff, Arizona: Best Publishing, 1995;141–5Google Scholar
51Xue, L, Yu, Q, Zhang, H, Liu, Y, Wang, C, Wang, Y. Effect of large dose hyperbaric oxygenation therapy on prognosis and oxidative stress of acute permanent cerebral ischemic stroke in rats. Neurol Res 2008;30:389–93Google Scholar
52Huy, PT, Sauvaget, E. Idiopathic sudden sensorineural hearing loss is not an otologic emergency. Otol Neurotol 2005;26:896–902Google Scholar
53Uzun, G, Yildiz, S. Therapeutic window for the use of hyperbaric oxygen therapy in idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx 2008;35:318Google Scholar
54Treweek, S, James, PB. A cost analysis of monoplace hyperbaric oxygen therapy with and without recirculation. J Wound Care 2006;15:235–8Google Scholar